EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease

Katarzyna Czarzasta, Luminita H Pojoga iD

Journal of Endocrinology · 2024

DOI: 10.1530/joe-23-0341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Katarzyna Czarzasta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warszawa, Poland. Hauptthemen laut MEDLINE: Caveolin 1, Receptors, Mineralocorticoid, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decades, research has clearly established the important role of the mineralocorticoid receptor (MR) in both renal and extra-renal tissues. Recently, caveolin-1 (Cav-1) has emerged as a mediator of MR signaling in several tissues, with implications on cardiovascular and metabolic dysfunction. The main structural component of caveolae (plasma membrane invaginations with diverse functions), Cav-1 is a modulator of cardiovascular function, cellular glucose, and lipid homeostasis, via its effects on signal transduction pathways that mediate inflammatory responses and oxidative stress. In this review, we present evidence indicating an overlap between the roles of the MR and Cav-1 in cardiometabolic disease and the relevant signaling pathways involved. Furthermore, we discuss the potential use of Cav-1 as a biomarker and/or target for MR-mediated dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caveolin 1Receptors, MineralocorticoidCardiovascular DiseasesHumansAnimalsMetabolic DiseasesSignal Transduction

Stichwörter der Autor:innen

cardiovascularcaveolin-1metabolicmineralocorticoid receptor

Substanzen

Caveolin 1Receptors, Mineralocorticoid

Autor:innen und Institutionen

  • Department of Experimental and Clinical Physiology, Laboratory of Center for Preclinical Research, Medical University of Warsaw, Warszawa, Poland.
  • Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Luminita H Pojoga

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Czarzasta, K., & Pojoga, L. H. (2024). Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease. Journal of Endocrinology. https://doi.org/10.1530/joe-23-0341

Vancouver

Czarzasta K, Pojoga LH. Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease. Journal of Endocrinology. 2024. doi:10.1530/joe-23-0341

BibTeX
@article{Czarzasta2024,
  author = {Czarzasta, Katarzyna and Pojoga, Luminita H},
  title = {Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease},
  journal = {Journal of Endocrinology},
  year = {2024},
  doi = {10.1530/joe-23-0341}
}
Kostenlos starten →